Search Results for keywords:"Pharmaron Manufacturing Services"

Found 2 results

Search Results: keywords:"Pharmaron Manufacturing Services"

💰 Only
Oldest Newest
  • 2025-05056 — Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
    Type:Notice
    Citation:90 FR 13782
    Reading Time:about a minute or two

    Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of certain controlled substances. The Drug Enforcement Administration (DEA) announced this application and is inviting comments and requests for hearings from other registered bulk manufacturers and applicants until April 25, 2025. The company aims to use the imported substances for analytical purposes and production processes but is not authorized for commercial sale of finished dosage forms. The submission of comments should be done electronically through the Federal eRulemaking Portal.

    Simple Explanation

    Pharmaron wants to bring in some special chemicals that are controlled and get permission to use them in their labs. The government is telling people about this and asking if anyone has any questions or wants to talk about it by April 25, 2025.

  • 2025-05055 — Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC
    Type:Notice
    Citation:90 FR 13782
    Reading Time:about a minute or two

    Pharmaron Manufacturing Services (US), LLC has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of certain controlled substances. This registration is intended to allow the company to produce materials for clinical trials. Interested parties can submit comments or request a hearing on the application by May 27, 2025, via the Federal eRulemaking Portal. The application was officially filed on February 11, 2025, and no other activities related to these substances are authorized beyond clinical trial production.

    Simple Explanation

    Pharmaron wants permission from a government group to make special medicines for testing, but some details about what they'll make and how it might affect others are missing. People can say what they think about this plan by a certain date, but they might not see what others have said right away.